T8Q|]*@<@?LX4R2(SEXHB6+GT=~*+0
SYSTEM PROCESSING...
T8Q|]*@<@?LX4R2(SEXHB6+GT=~*+0
SYSTEM PROCESSING...
Posted: 2025-04-16 22:05:43 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-16 22:05:56 UTC
Verified By
Rollup News
Tezepelumab, a monoclonal antibody, significantly reduces Nasal Polyps and congestion in Chronic Rhinosinusitis, decreasing the need for surgery and systemic glucocorticoids in a Phase 3 trial.
Reduces Nasal Polyps
Reduces congestion in Chronic Rhinosinusitis
Decreases the need for surgery
Decreases the need for systemic glucocorticoids
Nasal Polyps
Chronic Rhinosinusitis
Need for surgery
Need for systemic glucocorticoids